Global Life Science Ventures
Global Life Science Ventures (GLSV) is a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV is dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund may also invest in selected later stage companies, including buy-outs. For this purpose, GLSV provides finance, advice and access to expertise and networks. The group currently advises and manages funds totalling more than € 200 million. With offices in Germany and Switzerland, GLSV acts as one team with a global perspective.
Recent Milestones
Investments
Videos
Sources
-
Denmark's Santaris Grabs $12M From Insiders for Clinical Trials (pevc.dowjones.com)
[edit]
-
Action Pharma, A/S: Series C $6.3M (onbiovc.com)
[edit]
-
Coapt Systems takes $3.7M for facial rejuvenation (deals.venturebeat.com)
[edit]
-
Agendia closes $23M Series E financing (fiercebiotech.com)
[edit]
-
Agendia BV raises $34M and Receives Second FDA Clearance (agendia.com)
[edit]
-
Coapt Systems, maker of aesthetic surgery implants, raises $22.6M more (deals.venturebeat.com)
[edit]
-
EDGAR
[edit]